Kestra Medical Technologies (KMTS) shares rose in their debut on Nasdaq Thursday after the company priced its initial public offering of about 11.9 million shares at $17.00 per share.
The shares were up over 30% at $22.13 in recent trading after opening at $22.95.
Underwriters, including BofA Securities and Goldman Sachs, will have a 30-day option to buy up to almost 1.8 million additional shares, Kestra said. The offering is expected to close Friday.
Price: 22.35, Change: +5.35, Percent Change: +31.44
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.